Multidisciplinary management of orthopedic patients with sickle cell disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17190168.
- Also identified by DOI 10.3928/01477447-20061201-12.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
With pharmacological treatment, the lifespan of the patient with sickle cell disease can be extended to the sixth decade. Currently the only curative therapy for sickle cell disease is hemopoietic cell transplantation, which is still undergoing technical refinement. Most patients can be expected to undergo at least one orthopedic surgical procedure in their lifetime. Multidisciplinary management of orthopedic patients with sickle cell disease will decrease the overall complication rates and improve clinical outcomes.
Medical subject headings
- Anemia, Sickle Cell
- Orthopedic Procedures
- Osteomyelitis
- Osteonecrosis